Drag a card by its title · ⚙ to size, swap or remove

The company

Fate Therapeutics, Inc.

FATE · Nasdaq

Health CareBiotechnologyJust dropped out

FATE stood above a rising 150-day average in 34 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 12.9% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Just dropped out
Weeks in an uptrend: out for 1
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $646K
Officials’ trades on record: 1
Institutions holding: 146 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 34 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

1 disclosed lines: House 1, Senate 0, executive 0; 1 people.

Who	Did	Amount	Traded
Daniel S. Goldman House: U.S. House ClerkNY10	sold	$1k–$15k	31 Jan 2023filed 24 Feb 2023

Insiders

Buy orders, 12 months0

Sale orders, 12 months6

Buyers · sellers0 · 2

Who	Did	Shares	Traded
Bahram ValamehrPresident and CEO	sold	43,947at $2.46	4 Aug 2026filed 5 Aug 2026
Cindy TahlOfficer	sold	38,800at $2.46	4 Aug 2026filed 5 Aug 2026
Bahram ValamehrPresident and CEO	sold	28,946at $1.88	20 May 2026filed 21 May 2026
Cindy TahlOfficer	sold	25,590at $1.88	20 May 2026filed 21 May 2026
Bahram ValamehrPresident and CEO	sold	5,190at $1.07	9 Jan 2026filed 12 Jan 2026
Cindy TahlOfficer	sold	10,589at $1.06	9 Jan 2026filed 12 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders146+0 on the quarter

New · exited31 · 32

Reported value$178.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Redmile Group, LLCunchanged · filed 14 Aug 2026	12,872,946$34.8M	00.0%
BlackRock, Inc.reduced · filed 7 Aug 2026	7,298,895$19.7M	-2,769,719−27.5%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026	4,545,893$12.3M	+411,308+9.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	4,445,536$12.0M	+253,473+6.0%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026	3,837,229$10.4M	+835,708+27.8%
TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026	3,589,863$9.7M	+123,077+3.6%
JOHNSON & JOHNSONunchanged · filed 6 Aug 2026	3,379,064$9.1M	00.0%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026	2,983,268$8.1M	+8,585+0.3%
MILLENNIUM MANAGEMENT LLCnew · filed 14 Aug 2026	2,433,978$6.6M	+2,433,978
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026	2,049,187$5.5M	+721,430+54.3%